Genome-Wide Scan of nsSNPs
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - March 31, 2009
Grant ID
M2007030
Goals
These experiments propose to systematically screen all known common DNA variations to determine if they alter the risk of developing AMD. These experiments are expected to discover new pathways for developing AMD and improve our understanding of how the disease develops.
Summary
The discovery of genetic variation increasing the risk of macular degeneration has revolutionized our understanding of how patients lose vision from this condition. These discoveries have relied upon the study of changes in our DNA sequence in large groups of persons with and without macular degeneration. The genetic risks discovered to date change the sequence of proteins in our bodies. We believe that additional variation in protein sequence will be found to alter the risk of developing macular degeneration or its complications that lead to blindness.
Related Grants
Macular Degeneration Research
Studying the Role of Genes & the Tone of Our Eye Pigment in AMD
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Ruchi Sharma, PhD
Current Organization
National Eye Institute
Studying the Role of Genes & the Tone of Our Eye Pigment in AMD
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Ruchi Sharma, PhD
Current Organization
National Eye Institute
Macular Degeneration Research
The Role of Mitochondrial Dysfunction in Age-Related Macular Degeneration
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Navdeep Gogna, PhD
Current Organization
The Jackson Laboratory
The Role of Mitochondrial Dysfunction in Age-Related Macular Degeneration
Active Dates
July 01, 2023 - June 30, 2025
Principal Investigator
Navdeep Gogna, PhD
Current Organization
The Jackson Laboratory
Macular Degeneration Research
Machine Learning to Predict AMD-Associated Genetic Variant Impact
Active Dates
July 01, 2022 - December 31, 2025
Principal Investigator
Leah Vandenbosch, PhD
Current Organization
Seattle Children's Hospital
Machine Learning to Predict AMD-Associated Genetic Variant Impact
Active Dates
July 01, 2022 - December 31, 2025
Principal Investigator
Leah Vandenbosch, PhD
Current Organization
Seattle Children's Hospital